Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.

Pilz G, Wipfler P, Otto F, Hitzl W, Afazel S, Haschke-Becher E, Trinka E, Harrer A.

J Neuroinflammation. 2019 Jan 19;16(1):13. doi: 10.1186/s12974-019-1405-8.

2.

The Viral Hypothesis of Mesial Temporal Lobe Epilepsy - Is Human Herpes Virus-6 the Missing Link? A systematic review and meta-analysis.

Wipfler P, Dunn N, Beiki O, Trinka E, Fogdell-Hahn A.

Seizure. 2018 Jan;54:33-40. doi: 10.1016/j.seizure.2017.11.015. Epub 2017 Nov 24. Review.

3.

Human Herpesvirus 6B Induces Hypomethylation on Chromosome 17p13.3, Correlating with Increased Gene Expression and Virus Integration.

Engdahl E, Dunn N, Niehusmann P, Wideman S, Wipfler P, Becker AJ, Ekström TJ, Almgren M, Fogdell-Hahn A.

J Virol. 2017 May 12;91(11). pii: e02105-16. doi: 10.1128/JVI.02105-16. Print 2017 Jun 1.

4.

Coronary angiography as a rare cause for incomplete anterior spinal artery syndrome.

Pilz G, Wipfler P, Schwarte O, Golaszewski S, McCoy M, Haschke-Becher E, Hartung HP, Kraus J.

J Neurol. 2017 Apr;264(4):799-801. doi: 10.1007/s00415-017-8418-y. Epub 2017 Feb 22. No abstract available.

PMID:
28229242
5.

From natalizumab to fingolimod in eight weeks - Immunological, clinical, and radiological data in quest of the optimal switch.

Harrer A, Pilz G, Oppermann K, Sageder M, Afazel S, Haschke-Becher E, Rispens T, de Vries A, McCoy M, Stevanovic V, Hitzl W, Trinka E, Kraus J, Sellner J, Wipfler P.

Clin Immunol. 2017 Mar;176:87-93. doi: 10.1016/j.clim.2017.01.001. Epub 2017 Jan 17.

PMID:
28108364
6.

Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.

Karamyan A, Dünser MW, Wiebe DJ, Pilz G, Wipfler P, Chroust V, Novak HF, Hauer L, Trinka E, Sellner J.

PLoS One. 2016 May 31;11(5):e0155795. doi: 10.1371/journal.pone.0155795. eCollection 2016.

7.

Adaptive Immune Responses in a Multiple Sclerosis Patient with Acute Varicella-Zoster Virus Reactivation during Treatment with Fingolimod.

Harrer A, Wipfler P, Pilz G, Oppermann K, Haschke-Becher E, Afazel S, Kraus J, Trinka E, Sellner J.

Int J Mol Sci. 2015 Sep 10;16(9):21832-45. doi: 10.3390/ijms160921832.

8.

High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.

Harrer A, Pilz G, Wipfler P, Oppermann K, Sellner J, Hitzl W, Haschke-Becher E, Afazel S, Rispens T, van der Kleij D, Trinka E, Kraus J.

Clin Exp Immunol. 2015 Jun;180(3):383-92. doi: 10.1111/cei.12590. Epub 2015 Apr 27.

9.

Tumefactive MS lesions under fingolimod: a case report and literature review.

Pilz G, Harrer A, Wipfler P, Oppermann K, Sellner J, Fazekas F, Trinka E, Kraus J.

Neurology. 2013 Nov 5;81(19):1654-8. doi: 10.1212/01.wnl.0000435293.34351.11. Epub 2013 Oct 4. Review. Erratum in: Neurology. 2014 Apr 29;82(17):1569.

PMID:
24097813
10.

Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?

Wipfler P, Harrer A, Pilz G, Oppermann K, Afazel S, Haschke-Becher E, Sellner J, Trinka E, Kraus J.

Acta Neurol Scand. 2014 Mar;129(3):e12-5. doi: 10.1111/ane.12182. Epub 2013 Aug 30.

PMID:
24032536
11.

Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis.

Sellner J, Koczi W, Harrer A, Oppermann K, Obregon-Castrillo E, Pilz G, Wipfler P, Afazel S, Haschke-Becher E, Trinka E, Kraus J.

Clin Exp Immunol. 2013 Sep;173(3):381-9. doi: 10.1111/cei.12125.

12.

Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.

Wipfler P, Heikkinen A, Harrer A, Pilz G, Kunz A, Golaszewski SM, Reuss R, Oschmann P, Kraus J.

J Neurol. 2013 Jan;260(1):221-7. doi: 10.1007/s00415-012-6622-3. Epub 2012 Aug 9.

PMID:
22875099
13.

Biomarkers of inflammation and endothelial dysfunction in stroke with and without sleep apnea.

Kunz AB, Kraus J, Young P, Reuss R, Wipfler P, Oschmann P, Blaes F, Dziewas R.

Cerebrovasc Dis. 2012;33(5):453-60. doi: 10.1159/000336120. Epub 2012 Apr 5.

PMID:
22488018
14.

Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.

Harrer A, Pilz G, Einhaeupl M, Oppermann K, Hitzl W, Wipfler P, Sellner J, Golaszewski S, Afazel S, Haschke-Becher E, Trinka E, Kraus J.

PLoS One. 2012;7(2):e31784. doi: 10.1371/journal.pone.0031784. Epub 2012 Feb 20.

15.

Isolated leptomeningeal infiltration of a primary CNS B-cell lymphoma diagnosed by flow cytometry and confirmed by necropsy.

Broussalis E, Hutterer M, Oppermann K, Wipfler P, Pilz G, Harrer A, Haschke-Becher E, Golaszewski S, Schönauer U, Weis S, Killer-Oberpfalzer M, Mc Coy M, Trinka E, Kraus J.

Acta Neurol Scand. 2012 Sep;126(3):e11-6. doi: 10.1111/j.1600-0404.2011.01630.x. Epub 2011 Dec 26.

PMID:
22211863
16.

Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies.

Pilz G, Harrer A, Oppermann K, Wipfler P, Golaszewski S, Afazel S, Haschke-Becher E, Trinka E, Kraus J.

Mult Scler. 2012 Apr;18(4):506-9. doi: 10.1177/1352458511423650. Epub 2011 Sep 30.

PMID:
21965415
17.

Natalizumab therapy decreases surface expression of both VLA-heterodimer subunits on peripheral blood mononuclear cells.

Harrer A, Wipfler P, Einhaeupl M, Pilz G, Oppermann K, Hitzl W, Afazel S, Haschke-Becher E, Strasser P, Trinka E, Kraus J.

J Neuroimmunol. 2011 May;234(1-2):148-54. doi: 10.1016/j.jneuroim.2011.03.001. Epub 2011 Mar 29.

PMID:
21450349
18.

Acute pulmonary edema caused by a multiple sclerosis relapse.

Wipfler P, Pilz G, Broussalis E, Golaszewski SM, Kunz A, Trinka E, Kraus J.

J Neurol. 2011 Jun;258(6):1176-9. doi: 10.1007/s00415-011-5903-6. Epub 2011 Feb 1. No abstract available.

PMID:
21286744
19.

Recent developments in approved and oral multiple sclerosis treatment and an update on future treatment options.

Wipfler P, Harrer A, Pilz G, Oppermann K, Trinka E, Kraus J.

Drug Discov Today. 2011 Jan;16(1-2):8-21. doi: 10.1016/j.drudis.2010.10.011. Epub 2010 Nov 3. Review.

PMID:
21055477
20.

Relationship between thrombin generation and carotid intima-media thickness.

Bernhard H, Wipfler P, Leschnik B, Novak M, Kraus J, Pilz G, Ladurner G, Muntean W.

Hamostaseologie. 2010 Nov;30 Suppl 1:S168-71.

PMID:
21042684
21.

Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.

Wipfler P, Oppermann K, Pilz G, Afazel S, Haschke-Becher E, Harrer A, Huemer M, Kunz A, Golaszewski S, Staffen W, Ladurner G, Kraus J.

Mult Scler. 2011 Jan;17(1):16-23. doi: 10.1177/1352458510383075. Epub 2010 Oct 11.

PMID:
20937631
22.

Enhanced ozone strongly reduces carbon sink strength of adult beech (Fagus sylvatica)--resume from the free-air fumigation study at Kranzberg Forest.

Matyssek R, Wieser G, Ceulemans R, Rennenberg H, Pretzsch H, Haberer K, Löw M, Nunn AJ, Werner H, Wipfler P, Osswald W, Nikolova P, Hanke DE, Kraigher H, Tausz M, Bahnweg G, Kitao M, Dieler J, Sandermann H, Herbinger K, Grebenc T, Blumenröther M, Deckmyn G, Grams TE, Heerdt C, Leuchner M, Fabian P, Häberle KH.

Environ Pollut. 2010 Aug;158(8):2527-32. doi: 10.1016/j.envpol.2010.05.009. Epub 2010 Jun 8.

PMID:
20570421
23.

Invasive aspergillosis presenting with a painless complete ophthalmoplegia.

Wipfler P, Pilz G, Golaszewski S, Luthringshausen G, Berr F, Kemmerling R, Neureiter D, Ladurner G, Kraus J.

Clin Neurol Neurosurg. 2010 Jan;112(1):85-7. doi: 10.1016/j.clineuro.2009.10.012. Epub 2009 Nov 11.

PMID:
19910107
24.

Tree and stand growth of mature Norway spruce and European beech under long-term ozone fumigation.

Pretzsch H, Dieler J, Matyssek R, Wipfler P.

Environ Pollut. 2010 Apr;158(4):1061-70. doi: 10.1016/j.envpol.2009.07.035. Epub 2009 Aug 27.

PMID:
19713019
25.

Klebsiella meningoencephalitis presenting like embolic ischemic stroke.

Wipfler P, Pilz G, Lesicky O, Golaszewski SM, Ladurner G, Kraus J.

J Neurol. 2008 Dec;255(12):1983-4. doi: 10.1007/s00415-009-0046-8. Epub 2009 Jan 18. No abstract available.

PMID:
19153636
26.

Modern multiple sclerosis treatment - what is approved, what is on the horizon.

Pilz G, Wipfler P, Ladurner G, Kraus J.

Drug Discov Today. 2008 Dec;13(23-24):1013-25. doi: 10.1016/j.drudis.2008.08.003. Epub 2008 Sep 25. Review.

PMID:
18775508
27.

Modelling ozone effects on adult beech trees through simulation of defence, damage, and repair costs: Implementation of the CASIROZ ozone model in the ANAFORE forest model.

Deckmyn G, Op de Beeck M, Löw M, Then C, Verbeeck H, Wipfler P, Ceulemans R.

Plant Biol (Stuttg). 2007 Mar;9(2):320-30.

PMID:
17357024
28.

Exemplifying whole-plant ozone uptake in adult forest trees of contrasting species and site conditions.

Nunn AJ, Wieser G, Metzger U, Löw M, Wipfler P, Häberle KH, Matyssek R.

Environ Pollut. 2007 Apr;146(3):629-39. Epub 2006 Sep 22. Erratum in: Environ Pollut. 2008 Feb;151(3):678-9.

PMID:
16996178
29.

Growth of adult Norway spruce (Picea abies [L.] Karst.) and European beech (Fagus sylvatica L.) under free-air ozone fumigation.

Wipfler P, Seifert T, Heerdt C, Werner H, Pretzsch H.

Plant Biol (Stuttg). 2005 Nov;7(6):611-8.

PMID:
16388464

Supplemental Content

Loading ...
Support Center